Human Endogenous Retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods

Journal of Negative Results in BioMedicine

Volumn 12, Issue 1, 2013, Pages

  Jones, R Brad ^a,b   Leal, Fabio E ^c   Hasenkrug, Aaron M ^d   Segurado, Aluisio C ^c   Nixon, Douglas F ^d   Ostrowski, Mario A ^a,b   Kallas, Esper G ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HTLV 1 associated myelopathy tropical spastic paraparesis; HTLV I; Human endogenous retrovirus; T cells

Indexed keywords

EPITOPE; GAG PROTEIN; VIRUS ENVELOPE PROTEIN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; FEMALE; HTLV-1 ASSOCIATED MYELOPATHY TROPICAL SPASTIC PARAPARESIS; HTLV-1 INFECTION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MALE; NERVE CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SCHOOL CHILD; SCREENING TEST; SPINAL CORD DISEASE; T LYMPHOCYTE; TISSUES; TROPICAL SPASTIC PARAPARESIS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED;

ADULT; ENDOGENOUS RETROVIRUSES; FEMALE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; HTLV-I INFECTIONS; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES; YOUNG ADULT;

MLCS; MLOWN;

EID: 84872104653     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-12-3     Document Type: Article

References (21)

1. de The G, Bomford R: An HTLV-I vaccine: why, how, for whom. AIDS Res Hum Retroviruses 1993, 9:381-386.
2. Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, Goedert JJ, Blattner WA: Modelling the risk of adult T-cell leukemia/ lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989, 43:250-253.
3. Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS: The risk of development of HTLV-I-associated myelopathy/ tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990, 3:1096-1101.
4. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy, a new clinical entity. Lancet 1986, 1:1031-1032.
5. Goon PK, Igakura T, Hanon E, Mosley AJ, Asquith B, Gould KG, Taylor GP, Weber JN, Bangham CR: High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease. J Virol 2003, 77:9716-9722.
6. Montanheiro PA, Oliveira AC, Posada-Vergara MP, Milagres AC, Tauil C, Marchiori PE, Duarte AJ, Casseb J, et al: Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica 2005, 38:1643-1647.
7. Olindo S, Lezin A, Cabre P, Merle H, Saint-Vil M, Edimonana Kaptue M, Signate A, Cesaire R, Smadja D: HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression. J Neurol Sci 2005, 237:53-59.
8. Sakai JA, Nagai M, Brennan MB, Mora CA, Jacobson S: In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells. Blood 2001, 98:1506-1511.
9. Levin MC, Lee SM, Morcos Y, Brady J, Stuart J: Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry. J Infect Dis 2002, 186:1514-1517.
10. Tristem M: Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol 2000, 74:3715-3730.
11. Takahashi Y, Harashima N, Kajigaya S, Yokoyama H, Cherkasova E, McCoy JP, Hanada K, Mena O, Kurlander R, Tawab A, et al: Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells. J Clin Invest 2008, 118:1099-1109.
12. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, Erickson AL, Agrawal A, Spotts G, Hecht FM, et al: T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 2007, 3:e165.
13. SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, et al: Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J Virol 2011, 85:6977-6985.
14. Tandon R, SenGupta D, Ndhlovu LC, Vieira RG, Jones RB, York VA, Vieira VA, Sharp ER, Wiznia AA, Ostrowski MA, et al: Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1- infected subjects. J Virol 2011, 85:11526-11531.
15. Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, Martin E, John VM, Zhan W, Faruk NF, Gyenes G, Sheppard NC, Priumboom-Brees IM, Goodwin DA, Chen L, Rieger M, Muscat-King S, Loudon PT, Stanley C, Holditch SJ, Wong JC, Clayton K, Duan E, Song H, Xu Y, Sengupta D, Tandon R, Sacha JB, Brockman MA, Benko E, Kovacs C, Nixon DF, Ostrowski MA: HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. J Clin Invest 2012, 122(12):4473-4489. doi: 10.1172/JCI64560. Epub 2012 Nov 12.
16. Toufaily C, Landry S, Leib-Mosch C, Rassart E, Barbeau B: Activation of LTRs from Different Human Endogenous Retrovirus (HERV) Families by the HTLV-1 Tax Protein and T-Cell Activators. Viruses 2011, 3:2146-2159.
17. Antony JM, Deslauriers AM, Bhat RK, Ellestad KK, Power C: Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants. Biochim Biophys Acta 2011, 1812:162-176.
18. Hanon E, Goon P, Taylor GP, Hasegawa H, Tanaka Y, Weber JN, Bangham CR: High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood 2001, 98:721-726.
19. Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S: Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/ tropical spastic paraparesis: correlation with HTLV type 1 proviral load. AIDS Res Hum Retroviruses 2000, 16:1705-1709.
20. Wodarz D, Hall SE, Usuku K, Osame M, Ogg GS, McMichael AJ, Nowak MA, Bangham CR: Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proceedings 2001, 268:1215-1221.
21. Jones RB, John VM, Hunter DV, Martin E, Mujib S, Mihajlovic V, Burgers PC, Luider TM, Gyenes G, Sheppard NC, et al: HERV-K(HML-2) Gag and Env specific T cell responses are infrequently detected in HIV-1-infected subjects using standard peptide-matrix based screening. Clin Vaccine Immunol 2012, 19(2):288-292. doi: 10.1128/CVI.05583-11. Epub 2011 Dec 28.